MedPath

NEVIRAPINA KERN PHARMA 200 mg COMPRIMIDOS EFG

NEVIRAPINA KERN PHARMA 200 mg COMPRIMIDOS EFG

Commercialized
Register Number

74264

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jun 16, 2011

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number74264
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

NEVIRAPINAActive
Quantity: 200,00 mg
Name: NEVIRAPINA

ATC CLASSIFICATION (3)

J05A
J05AG
J05AG01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.